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 Infection, related to febrile neutropenia, in patients 
receiving chemotherapy for cancer remains a 
common complication and is a medical emergency. 
 Fever is often the only sign of severe underlying 
infection in neutropenic patients due to the patient’s 
immunosuppressed state (Butts, et.al, 2017). 
 Vigilant nursing assessment and immediate medical 
attention for neutropenic fever (NF) is imperative 
because the rate of major organ complication and 
mortality is as high as 30% and 11% respectively 
(Freifield et.al, 2011 & Taplitz et.al, 2018). 
 In the setting of severe sepsis or septic shock the 
mortality rate may be as high as 50% (Taplitz et.al, 
2018). 
 Reduced time to antibiotics has been shown to 
improve outcomes in patients with sepsis (Fletcher 
et.al, 2013). 
 Despite controversial outcomes related to door to 
antibiotic times in NF patients, the expert 
recommendation and current standard of practice 
uphold that initiation of antibiotics be administered 
within 60 minutes (Taplitz et.al, 2018 & Flowers et.al, 
2013). 
 NF patients frequently present to Emergency 
Department (ED) settings for evaluation and 
treatment ( Bow et.al, 2019). 
 Studies confirm significant delays in antibiotic 
administration, associated with NF patients, occur in 
the ED setting (Koenig et.al, 2019).
 As a result, increased length of stay, increased risk 
for adverse events, sepsis and even death can occur 
(Koenig et.al, 2019). 
 Providence Portland Medical Center’s (PPMC) 46-
bed ED is where cancer patients commonly present 
with NF and are provided nursing and medical care.
Background
n=5 n=5 n=7
 The Providence Oregon Regional Institutional Review Board 
approved this project.
 This was a retrospective chart review of adult cancer patients 
admitted with NF from PPMC’s ED to inpatient units between 
January 1st, 2018 to December 31st, 2019. 
 Inclusion criteria used to define the study population consisted 
of: age of at least 18 years old, active cancer diagnosis, 
received chemotherapy within 14 days of presentation to the 
ED, absolute neutrophil count (ANC) of less than or equal to 
1,000pu/L, and an oral temperature of equal to or greater than 
38.1 C.
 Data points included door to antibiotic (DTA) times, early 
identification of risk factors in triage note, demographics, vital 
signs, triage acuity using Emergency Severity Index (ESI) with 
1 being higher acuity than 5, types of venous access, and 
times of blood draws, and antibiotic orders.
The purpose of this study is to assess the door to antibiotic times, based 
on current standards of care of a 60-minute time frame, for cancer 
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 21 patients met inclusion criteria for this project.
 The average DTA time was 152 minutes with a range 
between 72 and 260 minutes (Figure 1).  
 The 2 outliers with the longest DTA times were mis-
triaged at a lower acuity of ESI-3.
 On arrival to the ED, patients self identified a risk factor of 
cancer, chemotherapy, or fever between 67 – 95% of the 
time.
 There were no significant DTA discrepancies between 
select populations except for ESI acuity (Figure 4).
 Delays were spread evenly between blood draw, ANC 

















Figure 3: Door to Antibiotic (DTA) and 
Venous Access Times
in ESI 2 Patients:
Comparing PICC, IV, & Port
n=17
Minutes to Access DTA
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 Lengthy DTA times suggest interventions are needed 
to address delays.
 A key limitation was the small sample size of 21 
patients.
 Assigning an ESI-2 triage acuity is recommended as 
lengthy delays were noted with ESI-3 patients (Figure 
4). 
 Time delays are spread throughout the DTA timeline 
suggesting that multiple workflow barriers exist 
throughout the ED encounter (Figure 2).
 Future projects should focus on process improvement 
towards rapid identification of febrile neutropenia, 
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Figure 4: Mean Door to Antibiotic Times
by Groups
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